Produktname:6-bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole

IUPAC Name:6-bromo-4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazole

CAS:1231930-33-8
Molekulare Formel:C11H12BrFN2
Reinheit:95%+
Katalognummer:CM130252
Molekulargewicht:271.13

Packungseinheit Verfügbarer Vorrat Preis($) Menge
CM130252-5g in stock ǺǠǠ
CM130252-25g in stock Ǡşƚ
CM130252-100g in stock ǺƩşƚ

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

   refresh    

Produkt-Details

CAS-Nr.:1231930-33-8
Molekulare Formel:C11H12BrFN2
Schmelzpunkt:-
SMILES-Code:CC2=NC1=C(F)C=C(Br)C=C1N2C(C)C
Dichte:
Katalognummer:CM130252
Molekulargewicht:271.13
Siedepunkt:
Mdl-Nr.:MFCD16660227
Lagerung:Store at room temperature.

Category Infos

Benzimidazoles
Benzimidazole is a benzo derivative of imidazole. It is a kind of bicyclic aromatic organic compounds, which is formed by fusing a six-membered benzene ring and five-membered imidazole at positions 4 and 5 of imidazole ring. It is an important pharmacophore of many biologically active heterocyclic compounds with various pharmacological activities. Benzimidazoles and their derivatives have developed into dynamic heterocyclic systems due to their potency in a variety of biologically active compounds such as anticancer, bactericidal and antiviral drugs. Benzimidazoles are a class of therapeutic motifs with broad relevance in medicinal chemistry.

Column Infos

Abemaciclib
Lilly announced the five-year results of a pre-planned analysis of Phase 3 MonarchE study, which evaluated two years of adjuvant Verzenio® (Abemaciclib) in combination with endocrine therapy (ET) compared with ET alone in patients with HR+, HER2-, node-positive early breast cancer (EBC) at a high risk of recurrence. Abemaciclib is the first and only CDK4/6 inhibitor approved for the treatment of node-positive, high-risk early breast cancer (EBC) patients.
Chemenu has been working to develop more compounds for drug discovery. Here are the building blocks we can provide.

Related Products